Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5472364 | 6395482 | F | 5472364-1 | 20030101 | 20070919 | 20070930 | EXP | CA-SHR-CA-2007-031016 | BERLEX | 43 | YR | F | Y | 84 | KG | 20070928 | CANADA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5472364 | 1008989676 | PS | BETASERON | 1 | SUBCUTANEOUS | 8 MIU, EVERY 2D | |||||
5472364 | 1008989677 | C | BACLOFEN | 1 | ORAL | ||||||
5472364 | 1008989678 | C | GABAPENTIN | 1 | ORAL | ||||||
5472364 | 1008989679 | C | LORAZEPAM | 1 | ORAL | ||||||
5472364 | 1008989680 | C | NADOLOL | 1 | ORAL | ||||||
5472364 | 1008989681 | C | OXYCOCET | 2 | ORAL | ||||||
5472364 | 1008989682 | C | OXYCODONE HCL | 1 | ORAL | ||||||
5472364 | 1008989683 | C | HYDROCHLOROTHIAZIDE | 1 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5472364 | 1008989676 | RELAPSING-REMITTING MULTIPLE SCLEROSIS |
5472364 | 1008989679 | SEDATIVE THERAPY |
5472364 | 1008989680 | HYPERTENSION |
5472364 | 1008989681 | PAIN |
5472364 | 1008989682 | PAIN |
5472364 | 1008989683 | HYPERTENSION |
Outcome of event
Event ID | OUTC COD |
---|---|
5472364 | HO |
5472364 | OT |
Reactions reported
Event ID | PT |
---|---|
5472364 | ACCIDENT |
5472364 | HIP SURGERY |
5472364 | HOT FLUSH |
5472364 | INJECTION SITE ERYTHEMA |
5472364 | LIMB INJURY |
5472364 | URTICARIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5472364 | 1008989676 | 20010607 |